• SENSEX 81,425.15
    323.83 (+0.40%)
  • BANKNIFTY 54,536.00
    319.90 (+0.59%)
  • N S D L
    1,301.00 880.00(%)
  • Vikram Solar
    407.85 381.70(%)
  • Kotak Mah. Bank
    1,990.00 2,301.55(%)
  • Avanti Feeds
    767.45 965.00(%)
  • Waaree Energies
    3,501.00 3,740.75(%)
  • MIC Electronics
    78.02 114.74(%)
  • Netweb Technol.
    3,217.95 3,312.00(%)
  • Bharat Electron
    389.00 435.95(%)
  • ICICI Bank
    1,416.35 1,494.10(%)
  • Timken India
    3,030.00 3,955.10(%)
  • TCS
    3,122.00 4,548.00(%)
  • Maruti Suzuki
    15,077.60 10,725.00(%)
  • Oracle Fin.Serv.
    9,299.00 13,203.60(%)
  • One Mobikwik
    299.35 218.85(%)
  • Infosys
    1,534.50 2,006.80(%)
  • Mamata Machinery
    492.00 649.00(%)
  • Vodafone Idea
    7.50 13.75(%)
  • M & M
    3,592.15 2,360.45(%)
  • Reliance Industr
    1,388.65 1,551.00(%)
  • Welspun Living
    128.25 188.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Amanta Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 23748.0
  • ISIN : INE084K01015
148.72 7 (4.92%)
  • As on 10 Sep 2025 (EOD)
  • Today’s Low

    140.35
  • Today’s High

    148.83
  • Open

    143.70
  • Perv Close

    141.75
  • 52W Low

    132.00
  • 52W High

    141.75

Key Indicators

  • P/E(TTM)

    51.71

  • Mar.Cap (₹Cr.)

    550.41

  • Div & Yield %

    0.00

  • Book Value(₹)

    57.27

  • Debt-Equity Ratio

    4.92

  • AGM Date

    10-Sep-2025

  • EPS

    2.72

  • P/E Ratio

    51.71

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    550.41

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    38.83

  • BV (₹)

    57.30

  • Sales( ₹ in Cr.)

    274.71

  • NP (in Cr.)

    10.57

  • NP Var(%)

    190.0

  • Div%

    0.0

  • CPS (₹)

    7.50

  • EPS (₹)

    2.70

  • Traded Value (₹ in Lakhs)

    546.13

  • 52 Week High

    141.75

  • 52 Week Low

    132.00

  • Price BSE

    141.0

  • Price NSE

    142.00

  • Market Capital( in Cr.)

    546.13

  • P/C Ratio

    18.90

  • P/E Ratio

    51.80

  • Price Vs.BV

    2.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 274.71 280.34 259.13 225.44 171.29 184.37
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 274.71 280.34 259.13 225.44 171.29 184.37
Other Income 1.39 1.27 3.57 76.09 1.06 2.13
Stock Adjustments 19.53 -17.31 -0.53 12.29 14.32 3.90
Total Income 295.63 264.30 262.17 313.82 186.67 190.40
EXPENDITURE :            
Raw Materials 76.99 52.82 101.24 89.09 63.84 67.72
Power and Fuel Cost 22.23 24.74 23.36 17.85 14.24 18.36
Employee Cost 36.34 32.55 31.87 39.59 34.43 33.29
Other Manufacturing Expenses 60.36 58.93 36.86 24.20 17.98 4.27
Selling and Administration Expenses 34.52 33.41 9.19 9.99 9.51 22.24
Miscellaneous Expenses 4.12 3.10 3.35 4.96 7.28 5.01
Employee Benefit Expenses 36.34 32.55 31.87 39.59 34.43 33.29
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 234.56 205.54 205.87 185.68 147.27 150.89
Operating Profit 61.06 58.76 56.31 128.15 39.40 39.50
Interest 27.95 33.64 35.27 48.88 40.13 38.13
Gross Profit 33.11 25.12 21.04 79.27 -0.73 1.37
Depreciation 18.40 19.73 18.35 17.34 17.02 16.49
Profit Before Tax 14.71 5.39 2.69 61.93 -17.75 -15.12
Current Tax 3.59 4.10 -1.28 6.78 3.77 3.53
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.61 -2.35 6.09 0.04 0.31 0.23
Reported Net Profit 10.50 3.63 -2.11 55.11 -21.83 -18.87
Extraordinary Items -0.07 -0.01 0.00 67.84 0.00 0.00
Adjusted Net Profit 10.57 3.64 -2.11 -12.73 -21.83 -18.87
Adjustment below Net Profit -0.40 -0.23 0.00 -2.03 -2.03 0.00
P & L Balance brought forward 16.14 10.82 15.00 -40.71 -16.85 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations -2.33 -1.91 2.06 0.00 0.00 0.00
P & L Balance carried down 28.56 16.14 10.82 12.37 -40.71 -18.87
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 3.64 1.35 -0.79 20.54 -8.14 -7.04
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 33.43 24.71 23.44 23.25 2.71 10.85
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    63.56%

  • Public Share Holding

    36.44%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 14,306,208 14,306,208.00 14,306,208 14,306,208
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 14,306,208 36.84 14,306,208 8
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,100,000 7.98 3,100,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 7,272,866 18.73 7,247,703 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,372,866 26.71 10,347,703 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 300,190 0.77 300,190 1
Financial Institutions / Banks 384,311 0.99 384,311 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 556,845 1.43 556,845 8
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 143,955 0.37 143,955 2
Mutual Funds / UTI 956,851 2.46 956,851 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,258,038 8.39 3,258,038 15
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,600,190 14.42 5,600,190 30
2] Non Institution
Bodies Corporate 279,667 0.72 279,667 7
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 289,833 0.75 289,833 32
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,795,586 4.62 1,353,286 20
Individuals holding nominal share capital up to Rs. 1 lakh 6,080,000 15.66 5,592,338 30,589
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,550,087 22.02 7,620,125 30,652
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 38,829,351 100.00 37,874,226 30,695

Company Background

Amanta Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Amanta Healthcare Ltd
  • BSE Code : 23748.0
  • ISIN : INE084K01015
  • Incorporation Year

    1994

  • Registered Office

    8th Floor Shaligram Corporates
    C.J.Marg Ambli, Ahmedabad,
    Gujarat-380058

  • Telephone

    079 6777 7600

  • FAX

  • Chairman

    Rohitbhai J Patel

  • Managing Director

    Bhaveshbhai G Patel

  • Company Secretary

    Shailesh Shah

  • Auditor

    S R Godiawala & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Amanta Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Amanta Healthcar 140.65 276.09 274.71 52.09 14.77
Abbott India 30,642.75 6,684.73 6,409.15 44.84 44.95
Astrazeneca Phar 9,105.75 1,756.92 1,716.29 124.16 32.94
P & G Health Ltd 6,467.70 944.52 934.17 35.72 40.23
Glaxosmi. Pharma 2,818.30 3,866.05 3,723.49 50.68 58.72
Cipla 1,551.85 20,029.57 19,044.85 23.19 21.40
Amrutanjan Healt 757.65 469.50 451.82 40.17 21.89
Guj. Themis Bio. 381.40 152.47 150.80 93.25 27.21
Fermenta Biotec. 356.80 442.21 430.53 11.84 17.61
Bliss GVS Pharma 153.65 703.42 667.20 22.97 9.16
Ambalal Sarabhai 31.84 19.33 4.04 16.67 2.10